U.S. Personal Products Stock News

In the past week, Robert Half Inc. participated in the 2026 Baird Global Consumer, Technology & Services Conference and saw its shares advance alongside a broad rally in staffing and employment services peers, while its subsidiary Protiviti secured a second U.S. patent for AI-driven automated data set matching technology. This combination of sector-wide optimism and Protiviti’s new AI patent highlights how Robert Half’s consulting and technology capabilities may be increasingly important to...

If you are wondering whether Hewlett Packard Enterprise (HPE) is still reasonably priced after its recent run, you are not alone. This article focuses squarely on what that current valuation might mean for you. HPE's share price recently closed at US$53.69, with returns of 40.5% over 7 days, 78.7% over 30 days, 122.1% year to date, and 209.9% over the last year, which naturally raises questions about growth potential and how risk is being priced in. Recent headlines around HPE have focused...

Legend Biotech (LEGN) is back in focus after early Phase 1 results for LB2501, its in vivo CD19/CD20 CAR-T candidate, showed a 100% response rate and favorable safety at the higher dose in difficult to treat lymphoma. See our latest analysis for Legend Biotech. The LB2501 update comes after a strong run in the stock, with a 7 day share price return of 21.02% and a 90 day share price return of 80.28%. However, the 3 year total shareholder return has declined 50.37%, so recent momentum...

In early June 2026, Arch Capital Group Ltd. priced US$600 million of 5.250% senior notes due 2036 and US$1.40 billions of 5.950% senior notes due 2056, while also launching cash tender offers of up to US$350 million to refinance existing debt and shifting to a single President model under Maamoun Rajeh following David Gansberg’s departure. The decision to expand Rajeh’s remit across insurance, reinsurance, and mortgage alongside large-scale debt issuance highlights Arch Capital’s focus on...

Recent analyst coverage of Ouster (OUST) has converged around a single theme: how its lidar and stereoscopic camera platform is gaining traction across real world automation, robotics, and smart infrastructure applications. See our latest analysis for Ouster. The stock’s recent client announcements with FieldAI and ARGUS, together with the launch of Rev8 and the Stereolabs acquisition, sit against strong momentum, with a 30 day share price return of 64.65% and a 1 year total shareholder...

What recent returns signal about Revvity stock Without a specific headline event setting the tone, Revvity (RVTY) has drawn investor attention through its recent performance, with the stock showing positive returns over the past week, month, and past 3 months. Over the past week, Revvity is up about 1.2%, adding to an advance of roughly 10.9% over the past month and 12.1% over the past 3 months. For context, the stock’s 1 year total return sits near 13.5%, while the 3 year and 5 year total...

MetLife stock performance snapshot MetLife (MET) has drawn investor attention after recent price moves, with the stock last closing at $83.46. The company reports annual revenue of $77.58b and net income of $3.43b, supported by multiple global business segments. See our latest analysis for MetLife. Recent trading has been firm, with a 1 day share price return of 3.09% and a 90 day share price return of 16.19%. The 5 year total shareholder return of 52.11% points to momentum that has built...

In late May 2026, NNN REIT raised its AFFO and core FFO per share guidance after reporting strong operating performance, high 98.6% occupancy, and closing US$145,000,000 of acquisitions across 41 properties with long-term net leases. This combination of upgraded guidance, robust leasing metrics, and ongoing portfolio growth highlights how NNN REIT is leaning on its net-lease retail model to reinforce cash flow resilience. We’ll now examine how the upgraded AFFO and core FFO guidance...

Stanley Black & Decker has continued to reshape its portfolio by selling non-core assets while maintaining its 50-year record of dividend increases, and its DEWALT brand has expanded trade support through new SkillsUSA and WorldSkills partnerships, as well as ongoing executive outreach via conferences now past or upcoming. This combination of business streamlining, sustained dividend growth, and deeper engagement with professional tradespeople highlights management’s focus on a leaner,...

Stock performance snapshot Wolverine World Wide (WWW) has seen its stock slip about 0.4% on the day, down around 10% over the past week and 5% over the past month, with year to date returns also lower. See our latest analysis for Wolverine World Wide. At a share price of US$15.93, Wolverine World Wide’s recent weakness, with the 7-day share price return down 10.25% and the year to date share price return down 12.52%, contrasts with a 3-year total shareholder return of 17.68%. This suggests...

In recent days, Warrior Met Coal reported that strong momentum in steelmaking coal prices, reaffirmed 2026 guidance, and the ongoing Blue Creek mine ramp-up have supported confidence in its outlook despite first-quarter earnings and revenue coming in below analyst expectations. This combination of higher commodity prices, record operational performance, and adherence to production plans has reinforced perceptions of the company’s resilience even when quarterly results miss forecasts. We’ll...

Monolithic Power Systems (NasdaqGS:MPWR) is scheduled to present at the COMPUTEX Forum 2026. The company plans to share updates on its technology roadmap, partnerships, and role in cloud infrastructure. Senior leadership is set to lead a session, signaling a focus on broader company direction and positioning. For investors watching the power semiconductor and cloud infrastructure space, this appearance puts NasdaqGS:MPWR directly in front of a global hardware and data center audience. The...

If you are wondering whether Varonis Systems at US$33.25 is priced attractively or not, you need more than just a quick glance at the recent chart. The stock has risen 4.5% over the past week and 21.3% over the past month, although it is still down 33.7% over the past year and 35.3% over the past five years, which can change how you think about both risk and opportunity. Recent attention on Varonis Systems has centered on its role in data security and governance, with investors weighing how...

Alignment Healthcare (ALHC) has been under sustained selling pressure over the past month after analyst downgrades from Barclays and Raymond James, setting the backdrop as the company heads into a high profile healthcare conference. See our latest analysis for Alignment Healthcare. That selling pressure shows up clearly in the numbers, with a 30 day share price return of down 17.65% and a year to date share price return of down 25.47%. However, the three year total shareholder return of...

Dyne Therapeutics has finished enrolling patients in the registrational expansion cohort of its Phase 1/2 ACHIEVE trial for zeleciment basivarsen in myotonic dystrophy type 1 (DM1). This moves the DM1 program into a pivotal stage that sets the timeline for Dyne’s next major regulatory filing and potential launch plans. Topline data from the ACHIEVE trial are expected in early 2027, supporting a planned U.S. Accelerated Approval submission. For investors watching NasdaqGS:DYN, the ACHIEVE...

In May 2026, QIAGEN N.V. announced research-use-only digital PCR assays for its QIAcuity platform to support Bundibugyo ebolavirus research, wastewater surveillance and environmental monitoring, targeting the virus’s NP and VP35 regions with designs based on publicly available outbreak genomic data. The launch highlights how QIAGEN’s adaptable Sample to Insight workflows can be rapidly configured around new pathogen targets, reinforcing its role in infectious disease and public health...

In May 2026, ANI Pharmaceuticals voluntarily initiated a Class II recall of 3,964 cartons of Estradiol Gel 0.1% across the US after the FDA reported defective packets that were empty or partially filled. At the same time, the company reported strong first-quarter 2026 results, raised its full-year revenue guidance to between US$1.08 billion and US$1.14 billion, and introduced a US$100 million share repurchase program, highlighting management’s confidence despite operational issues. We’ll...

In its recently reported fiscal second quarter, Energizer Holdings posted adjusted earnings that surpassed expectations, helped by tariff refunds and ongoing margin initiatives even as overall net sales declined. Separately, Aqua Capital, Ltd. disclosed an open-market purchase of 38,006 Energizer shares, bringing its direct holding to 7,200,000 shares and underscoring concentrated institutional interest alongside the company’s margin and pricing efforts. We’ll now examine how Energizer’s...

Jack Henry & Associates (NasdaqGS:JKHY) has announced that Board Chair David Foss will retire, with Matt Flanigan named as his successor. The transition follows a long period in which Foss has been closely involved in shaping the company’s direction and governance. For investors tracking NasdaqGS:JKHY, this boardroom change comes at a time when the stock is trading at $130.73 and has been under pressure, with the share price down 26.7% year to date and over the past 1 year. Over longer...

Talos Energy (NYSE:TALO) has closed its Zama transaction, reshaping its offshore Mexico portfolio. The company has secured new Gulf of Mexico leases, expanding its offshore project inventory. Talos reported Q1 results ahead of expectations, supported by strong new well productivity. Talos Energy comes into this news cycle with the stock trading at $15.3 and up 36.0% year to date. The share price is also up 94.2% over the past year, while the 5 year return is down 6.7%. This highlights both...

Wondering if Carrier Global at around US$68.54 is offering fair value or a potential mispricing opportunity? This article breaks down what the current share price might be telling you. The stock has recently moved, with returns of 7.4% over the last week, 6.8% over the last month, and 28.1% year to date. The return over the past year is down 2.6%, and up 56.6% over three years and 60.3% over five years. Recent coverage around Carrier Global has focused on its role in the building and HVAC...

Wondering whether Everpure at US$78.51 is offering good value or asking too much of future expectations? This article walks through what the current price might be implying about the company. The stock has returned 7.5% over the past week, 5.2% over the last month, 13.8% year to date and 43.8% over the past year, with a very large gain over five years of about 4x. Recent coverage around Everpure has focused on its role in the broader tech sector and how investors are reassessing growth...

Recent performance and context for Interparfums (IPAR) Interparfums (IPAR) has been on investors’ radar after a mixed period for the stock, with a modest gain in the past day contrasting with weaker moves over the past week and past 3 months. Over the past month the share price declined about 3%, and over the past 3 months it fell roughly 6%, while the stock is still up about 4% year to date. Over the past year, the total return declined about 33%, and over 3 years it declined about 29%,...

In early June 2026, New Jersey and the city of Newark filed lawsuits against GEO Group over alleged inhumane, unsanitary conditions at the Delaney Hall immigration detention facility and the company’s refusal to allow full state health inspections. The joint legal pressure from state and municipal authorities not only targets Delaney Hall’s operations but also elevates GEO Group’s regulatory and reputational exposure across its broader detention portfolio. We’ll examine how the legal push...